Frontline Immunotherapy Combined With Radiation and Chemotherapy in High Risk Endometrial Cancer
Status:
Recruiting
Trial end date:
2023-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this single arm, open label study is to evaluate the feasibility of
pembrolizumab combined with radiation administered to the upper part of the vagina (vaginal
cuff brachytherapy) followed by three cycles of pembrolizumab and chemotherapy in patients
with endometrial cancer.